Mirae Asset NYSE FANG+ ETF

 

The investment objective of the scheme is to generate returns, before expenses, that are commensurate with the performance of the NYSE FANG+ Total Return Index, subject to tracking error and forex movement. 

The Mirae Asset NYSE FANG+ ETF will be managed passively with investments in stocks in a proportion that match as close as possible to the weights of these stocks in NYSE FANG+ Index.

The NYSE FANG+ Index is an equal-dollar weighted Index designed to represent a segment of the technology and consumer discretionary sectors consisting of 10 highly-traded growth stocks of technology and tech-enabled companies.

About NYSE FANG+ Index : 

NYSE FANG+ Index constitutes of 10 stocks – Alibaba, Facebook, Alphabet, Apple, Baidu, Nvidia, Amazon, Netflix, Twitter, Tesla.

The NYSE FANG+ Index is an equal weighted Index designed to represent a segment of the technology and consumer discretionary sectors consisting of highly-traded growth stocks.

NYSE FANG+ Index sector and stock weighing

Stock Name	Weight (in %)
Baidu	14.4
Twitter	12.1
Alphabet	11
Netflix	9.4
NVIDIA	9.3
Apple	9.1
Tesla	9.1
Amazon	8.9
Facebook	8.6
Alibaba	8.3

 The periodical rebalancing occurs quarterly ○ Weight of each index constituents is set at 10% (equal weigh) on the date of rebalancing ○ Between the two-rebalancing quarter, the weight of each index constituents may drift due to price movement observed for each stock.

FANG+ : 

• Opportunity to take focused exposure in global innovation leaders. Single portfolio that potentially capture today’s global innovation leader.
• Companies that capture the current mega-trends. Megatrends are structural shifts that are long term in nature and are transformative force that has potential to change global economy, business and society.
• Geared for the future. 
• Focused to be a serial innovator and disruptor with an aim for excellence. Relentless focus on innovation may enable these companies to dominate in future too.
• Focused to keep an eye on external opportunity and threat. Along with Research & Development (R&D), FANG+ constituents are keeping an eye on potential opportunity and threat to their business.
• Disruptions change but producer of the disruptions are constant: NYSE FANG+ Index. In past, present or future, FANG+ companies were and are likely to be at the forefront of disruptive technologies. 
• NYSE FANG+ Index: At forefront of innovation then and now. FANG+ companies caused disruption before and are geared to do it in future too.
• FANG+ Stocks: Doing more than you think!. 
• Companies like Alphabet are focusing on other bets to find its next big revenue stream. Amazon and Alibaba are global giants of e-commerce with steady focus on other revenue stream too. Facebook and Apple both are diversifying at accelerated pace from their existing product line

Power of 10: 

• The combined power of NYSE FANG+ Index constituents
• Market Cap $7.7 Tn Could have been 03rd largest country in terms of GDP.
• Revenue $1.09 Tn 3x of Indian government total receipt FY 2019 -2020.
• Cash $500 Bn 85% of total forex reserve held by RBI in 2020.
• Net Income $179 Bn Exceeds combined net income of all Indian equities.
• FANG+ stocks aims to capture growth and scale across multiple parameters.

WHY INVEST IN THE FUND

• Focused and equal weighted exposure in innovative high growth technology, internet and media stocks
• Portfolio of companies which are geared to participate in future technology disruptions
• Provides passive international exposure predominately to US market at low cost
• Provides avenue to benefit also from INR depreciation

investing in US stocks 

ICICI Prudential FMCG ETF

 

ICICI Prudential FMCG ETF shall track NIFTY FMCG Index. The NIFTY FMCG Index comprises of 15 stocks from FMCG sector listed on the National Stock Exchange (NSE).

Index Constituents %
HINDUSTAN UNILEVER	29.3
ITC	23.5
NESTLE INDIA	8.4
TATA CONSUMER PRODUCTS	6
BRITANNIA INDUSTRIES	5.7
DABUR INDIA	4.4
GODREJ CONSUMER PRODUCTS	4.4
MARICO	3.6
JUBILANT FOODWORKS	3.1
COLGATE PALMOLIVE (INDIA)	3
UNITED SPIRITS	2.6
P&G HYGIENE & HEALTH CARE	1.7
EMAMI	1.5
VARUN BEVERAGES	1.4
UNITED BREWERIES	1.4

Performance(%) : Calendar Year Returns

	Nifty FMCG TRI	Nifty 50 TRI
2010	32.8	19.2
2011	10.2	-23.8
2012	50.4	29.3
2013	12.7	7.2
2014	19.4	32.9
2015	1.7	-3
2016	4.7	4.2
2017	31.2	30.3
2018	16	5.6
2019	0.5	13
2020	14.3	16
2021 (YTD)	6.9	12.9

NFO Details

NFO Details
NFO Period	New Fund Offer Opens on: July 20, 2021 New Fund Offer Closes on: August 02, 2021
Minimum Application Amount	Rs. 1,000 and in multiples of Re.1 thereafter
Minimum Amount for Application/Subscription (During Ongoing/Continuous Offer)	On Stock Exchanges: Investors can buy/sell units of the Scheme in round lot of 1 unit and in multiples thereof.
Benchmark	NIFTY FMCG TRI
Entry/exit load	NIL
Liquidity	To be listed

ICICI Prudential Nifty ETF (An open ended exchange traded fund tracking Nifty 50 Index) is suitable for investors who are seeking:*

• Long term wealth creation solution
• An Exchange Traded Fund that seeks to provide returns that closely
• correspond to the returns provided by Nifty 50 Index, subject to tracking error.

investment how to invest in ef
etf
fmcg

Rolex Rings Limited IPO

 

Subscribe

Incorporated in 2003, Rolex Rings is among the top five forging companies in India. The company manufactures hot rolled forged & machine bearing rings and automotive components that are used across segments i.e. passenger vehicles, 2-wheelers, commercial vehicles, electric vehicles, off-highway vehicles, industrial machinery, wind turbines, railways, etc. A wide range of product offerings such as automotive parts, hot forged and machined alloy steel bearing rings weighing from 0.01 Kg to 163+ kg caters to different industries i.e. automotive, industrial infrastructure, railways, renewable energy, etc.

Rolex Rings IPO Details

IPO Opening Date	Jul 28, 2021
IPO Closing Date	Jul 30, 2021
Issue Type	Book Built Issue IPO
Face Value	₹10 per equity share
IPO Price	₹880 to ₹900 per equity share
Market Lot	16 Shares
Min Order Quantity	16 Shares
Listing At	BSE, NSE
Issue Size	[.] Eq Shares of ₹10 (aggregating up to ₹731.00 Cr)
Fresh Issue	[.] Eq Shares of ₹10 (aggregating up to ₹56.00 Cr)
Offer for Sale	7,500,000 Eq Shares of ₹10 (aggregating up to ₹675.00 Cr)

Rolex Rings IPO Tentative Timetable

IPO Open Date	Jul 28, 2021
IPO Close Date	Jul 30, 2021
Basis of Allotment Date	Aug 4, 2021
Initiation of Refunds	Aug 5, 2021
Credit of Shares to Demat Account	Aug 6, 2021
IPO Listing Date	Aug 9, 2021

Rolex Rings IPO Lot Size

Application	Lots	Shares	Amount (Cut-off)
Minimum	1	16	₹14,400
Maximum	13	208	₹187,200

The Rolex Rings IPO market lot size is 16 shares. A retail-individual investor can apply for up to 13 lots (208 shares or ₹187,200).

Nippon India Flexi Cap Fund - NFO

 

Presenting a new fund that dynamically invests across time-appropriate market caps, with an aim to maximize your returns.

Stability through Large Caps & seeking growth opportunities through mid & small caps » Aims to leverage emerging trends before they become apparent

NFO Opens on : July 26, 2021

NFO Close Date: 9th August, 2021 

Investment Strategy

·        Market Cap allocation: The fund would invest across large, mid, and small caps based on market view and relative attractiveness.

·        Growth with Stability: While the fund will attempt to create Alpha or excess returns through bottom up stock selection and appropriate allocation to potentially high growth themes, it will maintain reasonable allocations to established leaders.

·        Accordingly, for Large Caps exposure, the deviation will be capped at 50% from the benchmark weight.

·        Well diversified portfolio across stock and sectors.

Investment approach

·        Lower deviation in mega caps

·        Active Divergence within rest of large cap basket

·        Mis and Small Caps: Focus on core growth + new age business

Investment Framework:

·        Market Cap: Large Cap deviation will be max 50% of Large Cap weight in the Benchmark (Nifty 500 TRI)

·        Active share: Active share is the percentage of fund holdings that is different from the benchmark holdings. A fund that has no holdings in common with the benchmark will have an Active Share of 100%, and a fund that has exactly the same holdings as the benchmark considered will have an Active Share of 0%. The fund would have an active share of 50 - 70%

·        Stock deviation: Top 5 stocks by weight in the Benchmark - for each stock max deviation of 40%

·        Stock Concentration: “ Based on Internal assessment of Business Risk, stocks have been classified under four rating buckets: A,B,C,D with A being the best and D being the worst. While it may appear all the investments should be concentrated in the A or B bucket, the stocks may not be reasonably priced. At the same time, stocks rated C or D may offer opportunities at reasonable valuations. Cummulative exposure: Max 45% in C, max 5% in D”

·        Sector deviation: Max deviation of financials - 8 %

 

Why invest in Nippon India Flexi Cap Fund?

•  Large investment universe
•  Diversification acoress market caps
•  Dynamic approach
• Participation in companies with cutting edge technology
• Potential for outperformance across market cycles

 

Other Scheme Details:

• Benchmark: NIFTY 500 TRI
• Minimum Application Amount: Rs. 500 in multiples of Rs. 1 thereafter
• Exit Load: 10% of the units allocated shall be redeem without any exit load, on or before completion of 12 months from the date of allotment of units. Any redemption in excess of such limit in the first 12 months from the date of allotment shall be subject to the following exit load.

Redemption of units would be done on First in First Out Basis (FIFO):

• 1% if redeemed or switched out on or before completion of 12 months from the date of allotment of units.
• Nil, thereafter
• Plans and Options: Growth Plan (Growth Option), Income Distribution cum Capital Withdrawal Plan (Payout Option and Reinvestment Option)

Mutual fund investment, hw to invest in mutual fund

Glenmark Life Sciences IPO

 

Glenmark Life Sciences is a wholly owned subsidiary of Glenmark Pharmaceuticals Limited.

It is the leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (APIs) in chronic therapeutic areas, including cardiovascular disease, central nervous system, pain management and diabetes. They also manufacture and sell APIs for gastro-intestinal disorders, anti-infectives and other therapeutic areas.

Currently its products are sold in India and exported to Europe, North America, Latin America, Japan, etc. It has 4 manufacturing facilities at Ankleshwar and Dahej in Gujarat and Mohol and Kurkumbh in Maharashtra State with an aggregate annual installed capacity of 725.8 KL as of 31st December 2020

Objects of the Issue:
Glenmark Life Sciences IPO Details

IPO Opening Date	Jul 27, 2021
IPO Closing Date	Jul 29, 2021
Issue Type	Book Built Issue IPO
Face Value	₹2 per equity share
IPO Price	₹695 to ₹720 per equity share
Market Lot	20 Shares
Min Order Quantity	20 Shares
Listing At	BSE, NSE
Issue Size	[.] Eq Shares of ₹2 (aggregating up to ₹1,513.60 Cr)
Fresh Issue	[.] Eq Shares of ₹2 (aggregating up to ₹1,060.00 Cr)
Offer for Sale	6,300,000 Eq Shares of ₹2 (aggregating up to ₹453.60 Cr)

Glenmark Life Sciences IPO Tentative Timetable

IPO Open Date	Jul 27, 2021
IPO Close Date	Jul 29, 2021
Basis of Allotment Date	Aug 3, 2021
Initiation of Refunds	Aug 4, 2021
Credit of Shares to Demat Account	Aug 5, 2021
IPO Listing Date	Aug 6, 2021

• 1) Offer for Sale (OFS) Rs 453.6 Crores: Under OFS selling shareholders would sell the shares and company would not get any proceeds from the issue.

  2) Fresh issue of Rs 1,060 Crores:

  i) To make payment of outstanding purchase consideration to the promoter for the spin-off of the API business from the promoter into the company.

  ii) To finance capital expenditure requirements.

  iii) To meet general corporate purposes.

The Glenmark Life Sciences IPO open date is Jul 27, 2021, and the close date is Jul 29, 2021. The issue may list on Aug 6, 2021.

Glenmark Life Sciences IPO Lot Size

The Glenmark Life Sciences IPO market lot size is 20 shares. A retail-individual investor can apply for up to 13 lots (260 shares or ₹187,200).

Application	Lots	Shares	Amount (Cut-off)
Minimum	1	20	₹14,400
Maximum	13	260	₹187,200

IPO how to invest in share market